|
US3691016A
(en)
|
1970-04-17 |
1972-09-12 |
Monsanto Co |
Process for the preparation of insoluble enzymes
|
|
CA1023287A
(en)
|
1972-12-08 |
1977-12-27 |
Boehringer Mannheim G.M.B.H. |
Process for the preparation of carrier-bound proteins
|
|
US4351337A
(en)
|
1973-05-17 |
1982-09-28 |
Arthur D. Little, Inc. |
Biodegradable, implantable drug delivery device, and process for preparing and using the same
|
|
US3941763A
(en)
|
1975-03-28 |
1976-03-02 |
American Home Products Corporation |
PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates
|
|
US4195128A
(en)
|
1976-05-03 |
1980-03-25 |
Bayer Aktiengesellschaft |
Polymeric carrier bound ligands
|
|
US4083368A
(en)
|
1976-09-01 |
1978-04-11 |
Freezer Winthrop J |
Inhaler
|
|
US4330440A
(en)
|
1977-02-08 |
1982-05-18 |
Development Finance Corporation Of New Zealand |
Activated matrix and method of activation
|
|
CA1093991A
(en)
|
1977-02-17 |
1981-01-20 |
Hideo Hirohara |
Enzyme immobilization with pullulan gel
|
|
US4229537A
(en)
|
1978-02-09 |
1980-10-21 |
New York University |
Preparation of trichloro-s-triazine activated supports for coupling ligands
|
|
US5002936A
(en)
|
1985-04-12 |
1991-03-26 |
Seymour Lieberman |
Lipophilic complexes of pharmacologically active inorganic mineral acid esters of organic compounds
|
|
US5206344A
(en)
|
1985-06-26 |
1993-04-27 |
Cetus Oncology Corporation |
Interleukin-2 muteins and polymer conjugation thereof
|
|
AU610083B2
(en)
|
1986-08-18 |
1991-05-16 |
Clinical Technologies Associates, Inc. |
Delivery systems for pharmacological agents
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
EP0281604B1
(en)
|
1986-09-02 |
1993-03-31 |
Enzon Labs Inc. |
Single polypeptide chain binding molecules
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
AU607172B2
(en)
|
1986-12-22 |
1991-02-28 |
Cygnus, Inc. |
Diffusion matrix for transdermal drug administration
|
|
US5023084A
(en)
|
1986-12-29 |
1991-06-11 |
Rutgers, The State University Of New Jersey |
Transdermal estrogen/progestin dosage unit, system and process
|
|
US4906169A
(en)
|
1986-12-29 |
1990-03-06 |
Rutgers, The State University Of New Jersey |
Transdermal estrogen/progestin dosage unit, system and process
|
|
US4983395A
(en)
|
1987-11-12 |
1991-01-08 |
Theratech Inc. |
Device for administering an active agent to the skin or mucosa
|
|
US4849224A
(en)
|
1987-11-12 |
1989-07-18 |
Theratech Inc. |
Device for administering an active agent to the skin or mucosa
|
|
US4847325A
(en)
|
1988-01-20 |
1989-07-11 |
Cetus Corporation |
Conjugation of polymer to colony stimulating factor-1
|
|
EP0387319B1
(en)
|
1988-07-23 |
1996-03-06 |
Delta Biotechnology Limited |
Secretory leader sequences
|
|
US4925677A
(en)
|
1988-08-31 |
1990-05-15 |
Theratech, Inc. |
Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
|
|
US4994439A
(en)
|
1989-01-19 |
1991-02-19 |
California Biotechnology Inc. |
Transmembrane formulations for drug administration
|
|
US5166322A
(en)
|
1989-04-21 |
1992-11-24 |
Genetics Institute |
Cysteine added variants of interleukin-3 and chemical modifications thereof
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5171264A
(en)
|
1990-02-28 |
1992-12-15 |
Massachusetts Institute Of Technology |
Immobilized polyethylene oxide star molecules for bioapplications
|
|
US6552170B1
(en)
|
1990-04-06 |
2003-04-22 |
Amgen Inc. |
PEGylation reagents and compounds formed therewith
|
|
JP3051145B2
(ja)
|
1990-08-28 |
2000-06-12 |
住友製薬株式会社 |
新規なポリエチレングリコール誘導体修飾ペプチド
|
|
US5252714A
(en)
|
1990-11-28 |
1993-10-12 |
The University Of Alabama In Huntsville |
Preparation and use of polyethylene glycol propionaldehyde
|
|
ATE240740T1
(de)
|
1991-03-15 |
2003-06-15 |
Amgen Inc |
Pegylation von polypeptiden
|
|
JP3507486B2
(ja)
|
1991-03-15 |
2004-03-15 |
アムジエン・インコーポレーテツド |
顆粒球コロニー刺激因子の肺内投与
|
|
ATE207080T1
(de)
|
1991-11-25 |
2001-11-15 |
Enzon Inc |
Multivalente antigen-bindende proteine
|
|
US5792451A
(en)
|
1994-03-02 |
1998-08-11 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
|
JPH0640945A
(ja)
|
1992-07-23 |
1994-02-15 |
Kureha Chem Ind Co Ltd |
Ｆｃフラグメント結合抗腫瘍剤
|
|
AU5171293A
(en)
|
1992-10-14 |
1994-05-09 |
Regents Of The University Of Colorado, The |
Ion-pairing of drugs for improved efficacy and delivery
|
|
US5346701A
(en)
|
1993-02-22 |
1994-09-13 |
Theratech, Inc. |
Transmucosal delivery of macromolecular drugs
|
|
US5432155A
(en)
|
1993-06-29 |
1995-07-11 |
The Salk Institute For Biological Studies |
Conotoxins I
|
|
US5514774A
(en)
|
1993-06-29 |
1996-05-07 |
University Of Utah Research Foundation |
Conotoxin peptides
|
|
US5460820B1
(en)
|
1993-08-03 |
1999-08-03 |
Theratech Inc |
Method for providing testosterone and optionally estrogen replacement therapy to women
|
|
US6342225B1
(en)
|
1993-08-13 |
2002-01-29 |
Deutshces Wollforschungsinstitut |
Pharmaceutical active conjugates
|
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5919455A
(en)
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5446090A
(en)
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
|
JPH09509428A
(ja)
|
1994-02-23 |
1997-09-22 |
カイロン コーポレイション |
薬理学的に活性な薬剤の血清半減期を増加させるための方法および組成物
|
|
FR2717688B1
(fr)
|
1994-03-28 |
1996-07-05 |
Lhd Lab Hygiene Dietetique |
Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.
|
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
|
WO1996019205A1
(en)
|
1994-12-21 |
1996-06-27 |
Theratech, Inc. |
Transdermal delivery system with adhesive overlay and peel seal disc
|
|
EE9700138A
(et)
|
1994-12-22 |
1997-12-15 |
Astra Aktiebolag |
Aerosoolravimvormid
|
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
US5739277A
(en)
|
1995-04-14 |
1998-04-14 |
Genentech Inc. |
Altered polypeptides with increased half-life
|
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
|
US5776896A
(en)
|
1996-01-03 |
1998-07-07 |
Zeneca Limited |
Analgesic peptides from venom of grammostola spatulata and use thereof
|
|
US5756663A
(en)
|
1996-01-03 |
1998-05-26 |
Zeneca Limited |
Antiarrhythmic peptide from venom of spider Grammostola spatulata
|
|
JP4046354B2
(ja)
|
1996-03-18 |
2008-02-13 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
増大した半減期を有する免疫グロブリン様ドメイン
|
|
US5783208A
(en)
|
1996-07-19 |
1998-07-21 |
Theratech, Inc. |
Transdermal drug delivery matrix for coadministering estradiol and another steroid
|
|
US6077680A
(en)
|
1996-11-27 |
2000-06-20 |
The University Of Florida |
ShK toxin compositions and methods of use
|
|
JP4212651B2
(ja)
|
1996-12-26 |
2009-01-21 |
サントリー株式会社 |
サソリ由来神経ペプチド
|
|
US6548644B1
(en)
|
1997-03-10 |
2003-04-15 |
Immunex Corporation |
Site protected protein modification
|
|
US5990237A
(en)
|
1997-05-21 |
1999-11-23 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
|
|
JP3530004B2
(ja)
|
1998-02-06 |
2004-05-24 |
株式会社日立ユニシアオートモティブ |
吸入式投薬器
|
|
US6022952A
(en)
|
1998-04-01 |
2000-02-08 |
University Of Alberta |
Compositions and methods for protein secretion
|
|
US6451986B1
(en)
|
1998-06-22 |
2002-09-17 |
Immunex Corporation |
Site specific protein modification
|
|
AUPP589598A0
(en)
|
1998-09-14 |
1998-10-08 |
University Of Queensland, The |
Novel peptides
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
JP4475814B2
(ja)
|
1998-11-20 |
2010-06-09 |
扶桑薬品工業株式会社 |
タンパク質発現ベクターとその使用
|
|
US6245740B1
(en)
|
1998-12-23 |
2001-06-12 |
Amgen Inc. |
Polyol:oil suspensions for the sustained release of proteins
|
|
JP2002533378A
(ja)
|
1998-12-23 |
2002-10-08 |
アムジエン・インコーポレーテツド |
タンパク質の徐放用ポリオール／油懸濁液
|
|
AU4010400A
(en)
|
1999-03-18 |
2000-10-04 |
Human Genome Sciences, Inc. |
27 human secreted proteins
|
|
US6887470B1
(en)
|
1999-09-10 |
2005-05-03 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
DE1252330T1
(de)
|
1999-11-26 |
2003-11-27 |
Mcgill University, Montreal |
Loci der idiopathischen epilepsie, mutationen derselben und verfahren zu deren verwendung zur feststellung, prognose und behandlung von epilepsie
|
|
WO2001054472A2
(en)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
US6602498B2
(en)
|
2000-02-22 |
2003-08-05 |
Shearwater Corporation |
N-maleimidyl polymer derivatives
|
|
SE0000935D0
(sv)
|
2000-03-21 |
2000-03-21 |
Astrazeneca Ab |
An inhalation device
|
|
US7125847B1
(en)
|
2000-04-07 |
2006-10-24 |
The Research Foundation Of State University Of New York At Buffalo |
Mechanically activated channel blocker
|
|
CN1133461C
(zh)
|
2000-04-11 |
2004-01-07 |
厦门北大之路生物工程有限公司 |
虎纹捕鸟蜘蛛毒素提取物在制备镇痛药物中的应用
|
|
EP2213743A1
(en)
|
2000-04-12 |
2010-08-04 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
DE60112424T2
(de)
|
2000-05-10 |
2006-05-24 |
Centre National De La Recherche Scientifique (Cnrs) |
Protonen-abhängiges na+-kanal hemmendes polypeptid
|
|
EP1177806A1
(en)
|
2000-08-04 |
2002-02-06 |
The Technology Partnership Public Limited Company |
Dry powder inhaler
|
|
GB0021617D0
(en)
|
2000-09-02 |
2000-10-18 |
Imp College Innovations Ltd |
Diagnosis and treatment of cancer
|
|
JP5013152B2
(ja)
|
2001-02-28 |
2012-08-29 |
株式会社ビーエムジー |
蛋白質複合体形成剤
|
|
AU2002335930B2
(en)
|
2001-03-09 |
2005-07-28 |
Morphosys Ag |
Serum albumin binding moieties
|
|
US20050054051A1
(en)
|
2001-04-12 |
2005-03-10 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
CA2443968A1
(en)
|
2001-04-12 |
2002-10-24 |
Imperial College Innovations Limited |
Diagnosis and treatment of cancer: i
|
|
GB0120238D0
(en)
|
2001-08-20 |
2001-10-10 |
Univ College Of London |
Sodium channel regulators and modulators
|
|
WO2003034988A2
(en)
|
2001-10-19 |
2003-05-01 |
Idexx Laboratories, Inc. |
Injectable compositions for the controlled delivery of pharmacologically active compound
|
|
US6900317B2
(en)
|
2002-02-19 |
2005-05-31 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
|
|
CA2474751A1
(en)
|
2002-02-25 |
2003-09-04 |
Vanderbilt University |
Expression system for human brain-specific voltage-gated sodium channel, type 1
|
|
US20030191056A1
(en)
|
2002-04-04 |
2003-10-09 |
Kenneth Walker |
Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
|
|
JP4638225B2
(ja)
|
2002-05-30 |
2011-02-23 |
ザ スクリプス リサーチ インスティテュート |
銅を触媒とするアジドとアセチレンのライゲーション
|
|
GB0219512D0
(en)
|
2002-08-21 |
2002-10-02 |
Norton Healthcare Ltd |
Inhalation compositions with high drug ratios
|
|
EP1609861B1
(en)
|
2003-03-26 |
2009-10-28 |
Pharmadesign, INC. |
Low-molecular weight peptides inhibiting ion channel activity
|
|
ATE385806T1
(de)
|
2003-06-12 |
2008-03-15 |
Lilly Co Eli |
Fusionsproteine
|
|
CN1894222A
(zh)
|
2003-08-05 |
2007-01-10 |
沃泰克斯药物股份有限公司 |
作为电压门控离子通道抑制剂的稠合嘧啶化合物
|
|
US7615563B2
(en)
|
2003-08-08 |
2009-11-10 |
Gonzalez Iii Jesus E |
Compositions useful as inhibitors of voltage-gated sodium channels
|
|
EP1673357A2
(en)
|
2003-08-08 |
2006-06-28 |
Vertex Pharmaceuticals Incorporated |
Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
|
|
US7060723B2
(en)
|
2003-08-29 |
2006-06-13 |
Allergan, Inc. |
Treating neurological disorders using selective antagonists of persistent sodium current
|
|
US7125908B2
(en)
|
2003-08-29 |
2006-10-24 |
Allergan, Inc. |
Treating pain using selective antagonists of persistent sodium current
|
|
EP1711517A4
(en)
|
2004-01-21 |
2008-02-13 |
Univ Utah Res Found |
MUTANT NAv1.7 SODIUM CHANNEL AND ASSOCIATED METHODS
|
|
WO2005118614A1
(en)
|
2004-04-08 |
2005-12-15 |
Avigen, Inc. |
Methods and compositions for treating neuropathic pain
|
|
EP1750683B1
(en)
|
2004-04-23 |
2013-01-09 |
Amgen Inc. |
Sustained release formulations
|
|
WO2006000116A1
(de)
|
2004-06-23 |
2006-01-05 |
Huber+Suhner Ag |
Breitband-patchantenne
|
|
GB0414272D0
(en)
|
2004-06-25 |
2004-07-28 |
Cellpep Sa |
OsK1 derivatives
|
|
US7259145B2
(en)
|
2004-07-07 |
2007-08-21 |
The Research Foundation Of State University Of New York |
Mechanically activated channel blocker
|
|
WO2006036834A2
(en)
|
2004-09-24 |
2006-04-06 |
Amgen Inc. |
MODIFIED Fc MOLECULES
|
|
AU2005294124B2
(en)
|
2004-10-07 |
2012-02-23 |
Bachem Biosciences, Inc. |
Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels
|
|
US7767680B2
(en)
|
2004-11-03 |
2010-08-03 |
Vertex Pharmaceuticals Incorporated |
Ion channel modulators and methods of use
|
|
US20060199812A1
(en)
|
2005-01-24 |
2006-09-07 |
Amgen Inc. |
Method of conjugating aminothiol containing molecules to vehicles
|
|
US7531523B2
(en)
|
2005-02-17 |
2009-05-12 |
Vertex Pharmaceuticals Incorporated |
Sodium channel protein type III alpha-subunit splice variant
|
|
US7833979B2
(en)
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
GB0517487D0
(en)
|
2005-08-26 |
2005-10-05 |
Isis Innovation |
Antibodies
|
|
US7972813B2
(en)
|
2005-09-30 |
2011-07-05 |
Vertex Pharmaceuticals Incorporated |
Tetrodotoxin-resistant sodium channel alpha subunit
|
|
JP2009514545A
(ja)
|
2005-11-08 |
2009-04-09 |
アテリス ラボラトリーズ |
μ−コノトキシンぺプチドおよびμ−コノトキシンぺプチドの局所麻酔薬としての使用
|
|
WO2007109324A2
(en)
|
2006-03-21 |
2007-09-27 |
Xenon Pharmaceuticals, Inc. |
Potent and selective nav 1.7 sodium channel blockers
|
|
EP2089426B1
(en)
|
2006-06-20 |
2016-04-20 |
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center |
Antimicrobial kinocidin compositions and methods of use
|
|
JP4742345B2
(ja)
*
|
2006-06-20 |
2011-08-10 |
独立行政法人産業技術総合研究所 |
カルシウムチャネルを遮断するグラモストラ・スパチュラタ由来のポリペプチドおよびその遺伝子
|
|
PE20081140A1
(es)
|
2006-10-25 |
2008-09-22 |
Amgen Inc |
Agentes terapeuticos a base de peptidos derivados de toxinas
|
|
WO2009033027A2
(en)
|
2007-09-05 |
2009-03-12 |
Medtronic, Inc. |
Suppression of scn9a gene expression and/or function for the treatment of pain
|
|
CN101480393A
(zh)
*
|
2008-01-07 |
2009-07-15 |
云南昊邦制药有限公司 |
草乌甲素作为制备治疗Nav1.7疼痛病症药物的应用
|
|
WO2009097530A2
(en)
|
2008-01-30 |
2009-08-06 |
Baylor College Of Medicine |
Peptides that target dorsal root ganglion neurons
|
|
ES2640817T3
(es)
|
2009-02-02 |
2017-11-06 |
Chromocell Corporation |
Líneas celulares que expresan Nav y métodos para su utilización
|
|
WO2010104115A1
(ja)
*
|
2009-03-10 |
2010-09-16 |
独立行政法人産業技術総合研究所 |
膜タンパク質を特異的に認識するポリペプチドの調製方法
|
|
WO2010104114A1
(ja)
*
|
2009-03-10 |
2010-09-16 |
独立行政法人産業技術総合研究所 |
ポリペプチドライブラリーを調製する方法
|
|
CA2755336C
(en)
|
2009-03-20 |
2015-07-14 |
Amgen Inc. |
Carrier immunoglobulins and uses thereof
|
|
AU2010296994B2
(en)
|
2009-09-15 |
2013-09-19 |
Alomone Preclinical Ltd. |
Novel peptides isolated from spider venom, and uses thereof
|
|
CN102781963B
(zh)
|
2009-10-27 |
2018-02-16 |
Ucb医药有限公司 |
功能修饰性NAv1.7抗体
|
|
GB0922435D0
(en)
|
2009-12-22 |
2010-02-03 |
Ucb Pharma Sa |
Method
|
|
GB0922434D0
(en)
|
2009-12-22 |
2010-02-03 |
Ucb Pharma Sa |
antibodies and fragments thereof
|
|
US8871996B2
(en)
|
2010-06-09 |
2014-10-28 |
Regeneron Pharmaceuticals, Inc. |
Mice expressing human voltage-gated sodium channels
|
|
US9279003B2
(en)
|
2010-07-07 |
2016-03-08 |
Purdue Pharma L.P. |
Analogs of sodium channel peptide toxin
|
|
CA2873860A1
(en)
|
2012-05-18 |
2013-11-21 |
Janssen Biotech, Inc. |
Huwentoxin-iv variants and methods of use
|